Tag: Giovanni Caforio
Weakness in Bristol Myers Squibb is a Big Opportunity
Bristol Myers Squibb (BMY) is on the move.
After plummeting from about $68 to a low of $54.60, the oversold stock is just starting to...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
*by submitting your information you agree to the terms of our Privacy Policy. You will receive FWeekly Stock Watch email and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.